Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, Hakim JG, Kumwenda J, Grinsztejn B, Pilotto JH, Godbole SV, Mehendale S, Chariyalertsak S, Santos BR, Mayer KH, Hoffman IF, Eshleman SH, Piwowar-Manning E, Wang L, Makhema J, Mills LA, de Bruyn G, Sanne I, Eron J, Gallant J, Havlir D, Swindells S, Ribaudo H, Elharrar V, Burns D, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Fleming TR; HPTN 052 Study Team.

N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.

PMID:
21767103
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil.

Remien RH, Bastos FI, Jnr VT, Raxach JC, Pinto RM, Parker RG, Berkman A, Hacker MA.

AIDS Care. 2007 Jul;19(6):740-8.

PMID:
17573593
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Universal access to antiretroviral therapy may be the best approach to 'Do no harm' in developing countries: the Brazilian experience.

Remien RH, Bastos FI, Berkman A, Terto V Jr, Raxach JC, Parker RG.

AIDS. 2003 Mar 28;17(5):786-7. No abstract available.

PMID:
12646815
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk